Answers are grounded in this paper and cite their sources.
Case reports identify rare resilience factors and insulin secretion in long-term type 1 diabetes, suggesting new treatment targets.
We present two patients with > 80 years with type 1 diabetes (T1D), but with minor complications. Their history and risk factors are characterized as are factors conferring resilience against angiopathy. Amazingly, both had clearly detectable C-peptide. The underlying reasons for their benign phenotype could form the basis for novel treatment targets.
No takes yet. Share an insight, caveat, or question.
Sjöholm et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: